SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001013762-23-005850
Filing Date
2023-10-23
Accepted
2023-10-23 17:00:04
Documents
5
Period of Report
2023-12-04

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ea187109-def14a_silopharma.htm DEF 14A 739270
2 GRAPHIC image_001.jpg GRAPHIC 4630
3 GRAPHIC image_002.jpg GRAPHIC 257088
4 GRAPHIC image_003.jpg GRAPHIC 325263
5 GRAPHIC image_004.jpg GRAPHIC 154732
  Complete submission text file 0001013762-23-005850.txt   1762235
Mailing Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632
Business Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

IRS No.: 462137136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41512 | Film No.: 231340459
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl